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Abstract
Purpose This study aims to study the effects of depression
and demoralization on suicidal ideation and to determine the
feasibility of the Distress Thermometer as a screening tool for
patients with cancer who experience depression and demoral-
ization, and thus to establish a model screening process for
suicide prevention.
Methods Purposive sampling was used to invite inpatients
and outpatients with lung cancer, leukemia, and lymphoma.
Two hundred participants completed the questionnaire, which
included the Distress Thermometer (DT), Patient Health
Questionnaire-9 (PHQ-9), Demoralization Scale-Mandarin
Version (DS-MV), and Beck Scale for Suicide Ideation. All
data obtained were analyzed using SPSS 18.0 and SAS 9.3.
Results Tobit regression analysis showed that demoralization
influenced suicidal ideationmore than depression did (t=2.84,
p<0.01). When PHQ-9≥10 and DS-MV ≥42 were used as
criteria for the DT, receiver operating characteristic analysis
revealed that the AUC values were 0.77–0.79, with optimal
cutoff points for both of DT ≥5; sensitivity 76.9 and 80.6 %,
respectively; and specificity of 73.9 and 72.2 %, respectively.
Conclusions Demoralization had more influence on suicidal
ideation than depression did. Therefore, attention should be
paid to highly demoralized patients with cancer or high de-
moralization comorbid with depression for the purposes of
suicide evaluation and prevention. The DTscale (with a cutoff
of ≥5 points) has discriminative ability as a screening tool for
demoralization or depression and can also be used in clinical
settings for the preliminary screening of patients with cancer
and high suicide risk.
Keywords Demoralization syndrome . Depression . Distress
thermometer . Suicide risk factor
Introduction
The risk of suicide is two to four times higher—and the
standardized mortality ratio (SMR) of suicide is 1–11 times
higher—in patients with cancer than in the general population
[1–5]. The suicide mortality rate of patients with cancer
reached 288.9/100,000/3 years in 2002–2004 in Taiwan [3],
higher than those reached 31.4/100,000 person-years in USA
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[4]. The standardized mortality ratio (SMR) of patients with
cancer is approximately 6.7 higher than those in other coun-
tries: South East England (male SMR 1.4; women SMR 1.19)
[6], Australian (SMR 1.78) [7], Korean (SMR 2) [8]. Indicat-
ing serious measures, suicide prevention among patients with
cancer in Taiwan needs to be undertaken. Past studies have
shown that suicide risk factors for patients with cancer include
the length of time after preliminary diagnosis [9–13], gender
[10, 14], type and stage of cancer [3, 9, 11], psychological
characteristics [5, 15], social support and economic resources
[4, 12], lack of detection by clinical staff [12, 16, 17], and so
on. Among the assessed psychological factors involved in
suicide risk, depression was regarded as the most important
predictor [16, 18, 19]. Several studies have found that the Distress
Thermometer (DT) [20–25], the Emotion Thermometer (ET)
[26, 27], and the Brief Symptom Rating Scale (BSRS-5) [28]
are highly accurate as a screening tool for depression. In
Taiwan, only the DTwas a valid measure for cancer patients
[25]. BSRS-5 had not validated for cancer patients population.
Thus, the DT can be used as a preliminary clinical screening
tool for patients with cancer and depression to facilitate refer-
ral to further services and prevention of suicide risk factors.
Aside from the elevated incidence of depression in patients
with cancer, there is also a higher incidence of demoralization
syndrome; studies conducted in Australia [29], America [30],
Ireland [31], Western Europe [32], Germany [33], Hungary
[34], and Taiwan [35] have produced similar results. The
concept of demoralization syndrome was proposed by
Kissane and Clarke; it is experienced as a persistent inability
to cope together with feelings of helplessness, hopelessness,
and incompetence and the loss of aims and meaning in life
[36]. However, some patients with cancer experience symp-
toms of demoralization without those of depression [29, 33,
35]. The diagnosis and treatment methods for demoralization
differ from those for depression [35, 36]. Both conditions can
exist independently, but they can also be comorbid with each
other [37]. Studies have shown that 14–27.4 % of patients
were demoralized but not depressed, while 21.7–33 % expe-
rienced both demoralization and depression [29, 35].
From the clinical study point of view [36], demoralization
is not necessarily related to psychiatric disorder; 29.5 % of the
patients were characterized by the absence of any DSM-IV
comorbid disorder. What is more serious is that there is a
statistically significant demoralization phenomenon among
cancer patient in Taiwan [35]. If clinical diagnosis is limited
to the DSM-IV diagnostic criteria for clinical depression
or adjustment disorder, the abovementioned patients
with cancer and severe demoralization will not be able
to receive proper treatment; this could lead to a higher
suicide risk for them [38, 39].
No previous research has investigated whether the presence
of comorbid depression and demoralization affects suicidal
ideation or whether the DT is suitable for the screening of
patients with severe demoralization. Therefore, this study
aims to investigate the relationships between psychological
distress, depression, and demoralization on one hand with
suicidal ideation on the other and to establish a model screen-
ing process for suicide prevention in patients with cancer.
Methods
Design and participants
The study was approved by the Mackay Memorial Hospital
Committee of Human Testing and passed the inspection of the
Institutional Review Board to allow clinical research
(11MMHIS097). Because of limitations in labor and time,
the study employed a questionnaire-based cross-sectional sur-
vey; data were collected from participants with lung cancer,
leukemia, and lymphoma, including inpatients and outpa-
tients, using purposive sampling. The exclusion criteria in-
cluded uncertainty regarding cancer diagnosis, unwillingness
to sign the participant consent form, inability to communicate
effectively, the presence of cognitive impairment, psychotic
illness, unable to understand written Chinese, unable to
fill out four different questionnaires completely, and less
than 20 years old.
Patients meeting these criteria were subsequently
approached by the attending physician that gave consent to
their patient’ participation. Patients were invited to take part in
the study and the study instruments were given by the research
assistants. The research assistants were Master’s candidates at
the Institute of Counseling, and both had received >2 years of
training in psychological counseling. Throughout the study,
both research assistants were available to provide emotional
support to the participants and refer them to psychooncology
staff if needed. The period of data collection was between
October 2011 and August 2012. In total, 209 participants
filled out questionnaires, 200 participants filled out four ques-
tionnaires completely, and 9 participants filled out only some
questionnaires. As mentioned above, six patients with cancer
were unable to comprehend the questionnaire or refused to
continuewith the interview, and three were unable to complete
four questionnaires for physiological reasons, leaving a total
of 200 valid questionnaires.
Measures
Beck scale for suicide ideation (BSI)
The Beck Scale for Suicide Ideation (BSI) was developed as a
self-reported measure according to Scale for Suicide Ideation
[40]. This questionnaire was used to measure the participants’
severity of suicidal ideation during the past week. The scoring
range of each question was 0–2 points (total range, 0–38
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points). There was no cutoff point for this measure; all scores
above 0 indicated the presence of suicidal ideation. Higher
scores indicate more severe suicidal ideation.
Distress thermometer
The DT is a self-report measure developed by the NCCN to
detect psychological stress in patients with cancer [41]. It
involves responding to a single question using a Likert scale
in the form of a thermometer to indicate the psychological
distress experienced within the past week (0 indicates no
distress; 10 indicates extreme distress).
Patient health questionnaire-9
The Patient Health Questionnaire (PHQ-9) was developed as a
self-reported measure [42]. Its nine questions assess the pres-
ence of the DSM-IV criteria for major depressive episodes
across a 2-week period using responses on a four-point Likert
scale. When the item scores are summed, a total score of ≥10
corresponds to a diagnosis of major depressive disorder with
sensitivity and specificity values of 88 % [42]. In Taiwanese
primary care settings, the PHQ-9 has satisfactory psychomet-
ric properties for the detection of major depressive disorder.
The mean of Cronbach’s α was 0.8 (95 % confidence interval
[CI], 0.79–0.82), and the optimal cutoff score of PHQ-9≥10
had 86 % sensitivity and 93.9 % specificity [43].
Demoralization scale-mandarin version
The Demoralization Scale-Mandarin Version (DS-MV) was
translated from the demoralization scale developed by
Kissane [29]. The DS-MV includes five distinct dimensions:
loss of meaning (five items; α=0.84), dysphoria (five items;
α=0.69), disheartenment (six items; α=0.88), helplessness
(four items; α=0.72), and sense of failure (four items;
α=0.63). The reliability and validity of the Mandarin version
for patients with cancer has been revealed in our previous
research (Cronbach’s α=0.92); thus, the DS-MV has accept-
able psychometric properties when used in Taiwanese patients
with cancer [44].
Statistical analysis
The statistical software packages SPSS 18.0 and SAS 9.3
were used for archiving and analysis. Independent-samples t
tests and ANOVAs were conducted to determine if there were
significant differences in demographics and disease character-
istics with respect to the different variables. With suicidal
ideation as the dependent variable, the data set violated the
assumption of the normality test (p<0.001), having a right-
skewed distribution. As the Tobit Model is suitable for testing
non-normally distributed, left-skewed, right-skewed, or
bilateral-intercepted data sets [45], the Tobit Model and Clas-
sification and Regression Tree (CART) were used to test the
power of psychological distress, depression, and demoraliza-
tion to predict suicidal ideation. The Sobel mediator test [46,
47] was also used to study the mediation effects of various
psychological variables on suicidal ideation. Finally, receiver
operating characteristic (ROC) [48] curves were computed to
examine the ability of the DT to identify depression and
demoralization. An ROC curve is a plot of a test’s true-
positive rate (sensitivity) over the false-positive rate (1−spec-
ificity) measured at each score cutoff value. The area under an
ROC curve is a summary measure of the probability that a
randomly drawn patient identified as a “case” will score
higher on the test in question than a randomly draw patient
who does not meet case criteria [49].
Results
Demographics and disease characteristics
Table 1 lists the demographics and disease characteristics of
the 200 included patients.
Differences in suicidal ideation, psychological distress,
depression, and demoralization on the bases of demographics
BSI score ≥1 was regarded as indicating the presence of
suicidal ideation (Table 1). A total of 59 patients (29.5 %)
with cancer had BSI scores ≥1 (mean BSI score, 3.88±4.04).
As shown in Table 1, there was one significant difference in
suicidal ideation with respect to marital status (F=3.08,
p≤0.05): unmarried participants had higher levels of suicidal
ideation than married participants had. There were no signif-
icant differences in suicidal ideation between participants with
other marital statuses.
The mean DT score was 3.46 (SD=2.48). A total 76
patients (36 %) scored ≥5 points on the DT, which (according
to NCCN standards [41]) implies that they have clinically
apparent features of psychological distress. Patients with lung
cancer had higher psychological distress than hematological
patients (t=2.56, p<0.05). There was one significant differ-
ence in psychological distress with respect to type of age
(F=3.92, p<0.05). Patients with 36–50 years old had higher
psychological distress compared to patients with 51–65 years
old, and to patients with above 65 years old.
The mean PHQ-9 score was 6.06 (SD=4.30). In this study,
39 patients with cancer (19.5 %) scored ≥10 points on the
PHQ-9, implying that they may have fulfilled the diagnostic
criteria for depression [43]. There were significant differences
in levels of depression with respect to education level
(F=4.00, p<0.05), employment status (t=−2.31, p<0.05),
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hospitalization status (t=−2.87, p<0.01), and type of malig-
nancy (t=−2.87, p<0.01). There were higher levels of depres-
sion in junior high school, unemployment, outpatient, and
lung cancer patient group.
The mean DS-MV score over all participants was 28.26
(SD=13.32). In accordance with Kissane et al. [29], those
scoring ≥30 points (84 participants, 42 %) can be regarded
as severely demoralized. An alternative suggested byMullane



















t F Mean (SD) t F
Gender −0.85 0.15 −1.57 −0.99
Female 105 (52.5 %) 0.98 (2.23) 3.49 (2.55) 5.61 (4.02) 27.37 (13.60)
Male 95 (47.5 %) 1.33 (3.34) 3.43 (2.40) 6.56 (4.56) 29.23 (13.01)
Age 0.93 3.92* 2.46 0.50
≤35 years 24 (12 %) 1.88 (3.14) 3.67 (2.01) 6.63 (3.93) 31.29 (10.45)
36–50 years 56 (28 %) 1.34 (3.43) 4.25 (2.39) 7.18 (4.64) 28.25 (15.88)
51–65 years 111 (55.5 %) 0.93 (2.42) 3.14 (2.54) 5.50 (4.11) 27.61 (12.34)
>65 years 9 (4.5 %) 0.67 (2.00) 1.89 (2.03) 4.56 (4.13) 28.11 (15.41)
Education 0.33 0.75 4.00* 2.40
Elementary school 31 (15.5 %) 0.81 (2.87) 3.26 (2.76) 4.26 (3.65) 29.39 (13.15)
Junior high school 33 (16.5 %) 1.39 (3.80) 3.88 (3.08) 8.18 (5.03) 34.18 (14.14)
Senior high school 59 (29.5 %) 1.15 (2.09) 3.25 (2.66) 5.88 (4.05) 25.92 (13.65)
College 64 (32 %) 1.28 (3.02) 3.67 (2.33) 6.28 (4.17) 27.31 (12.07)
Research institute 13 (6.5 %) 0.06 (1.50) 2.77 (1.74) 4.69 (3.38) 25.77 (13.06)
Marital status 3.08* 1.07 0.74 0.71
Never marred 45 (22.5 %) 2.02 (3.92) 3.71 (2.37) 6.53 (3.73) 30.76 (10.16)
Married 131 (65.5 %) 0.76 (2.05) 3.48 (2.53) 6.04 (4.50) 27.46 (13.89)
Divorced 18 (9 %) 2.00 (4.04) 3.22 (2.34) 5.78 (1.12) 27.50 (15.60)
Widowed 6 (3 %) 0.33 (0.82) 1.83 (2.40) 3.83 (4.35) 29.17 (15.28)
Employment status −1.91 −1.12 −2.31* −1.90
Yes 95 (47.5 %) 0.76 (2.06) 3.25 (2.50) 5.33 (3.77) 26.39 (13.15)
No 105 (52.5 %) 1.50 (3.32) 3.65 (2.46) 6.71 (4.65) 29.94 (13.30)
Hospitalization −0.48 1.58 −2.87** 2.56*
Outpatient 132 (46.5 %) 1.08 (2.63) 3.27 (2.36) 5.41 (3.91) 26.05 (13.14)
Inpatient 68 (53.5 %) 1.28 (3.14) 3.84 (2.67) 7.32 (4.74) 32.54 (12.70)
Type of malignancy 0.98 2.56* 2.69** −3.35**
Lung 93 (66 %) 1.35 (3.40) 3.94 (2.54) 6.94 (4.66) 30.81 (13.59)
Hematological 107 (34 %) 0.96 (2.17) 3.05 (2.36) 5.30 (3.81) 26.04 (12.74)
Cancer stage 1.69 0.76 0.98 0.33
Stage I 21 (10.5 %) 2.48 (4.59) 3.52 (2.33) 6.48 (4.03) 26.95 (12.80)
Stage II 27 (13.5 %) 1.56 (4.56) 3.56 (2.43) 6.00 (4.77) 26.26 (15.07)
Stage III 34 (17 %) 0.97 (2.17) 3.91 (2.38) 6.88 (4.15) 29.24 (13.81)
Stage IV 38 (19 %) 0.76 (1.76) 3.68 (2.40) 6.55 (4.28) 29.53 (12.82)
Unknown 80 (40 %) 0.91 (1.91) 3.11 (2.62) 5.39 (4.26) 28.25 (13.08)
Time since diagnosis 0.66 0.11 0.29 2.86*
<3 months 37 (18.5 %) 1.03 (3.62) 3.57 (2.59) 6.35 (4.51) 28.35 (11.44)
3 months–1 year 31 (15.5 %) 0.68 (1.30) 3.32 (2.21) 6.26 (5.22) 26.00 (11.19)
1–2 years 50 (25 %) 1.02 (2.33) 3.58 (2.59) 6.28 (4.15) 32.76 (13.01)
>2 years 82 (41 %) 1.45 (3.08) 3.39 (2.50) 5.72 (3.95) 26.32 (14.52)
Treatment −0.30 1.58 1.76 2.23*
Continued 141 (70.5 %) 1.11 (2.78) 3.64 (2.52) 6.40 (4.55) 29.6 (13.07)
Discontinued 59 (29.5 %) 1.24 (2.91) 3.03 (2.33) 5.24 (3.52) 25.03 (12.47)
SD Standard Deviation, t t statistics, F F statistics
*p<0.05; **p<0.01
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et al. [31] was to categorize patients as demoralized according
to the criterion of mean±1 standard deviation; by that criteri-
on, 31 participants (15.5 %) scoring >42 points (mean+SD=
28.26+13.32=41.58) could be categorized as highly
demoralized. There were significant differences in level of
demoralization with respect to current hospitalization status
(t=−3.35, p<0.01), whether treatment was continued or
discontinued (t=2.23, p<0.05), type of malignancy (t=2.56,
p<0.05), and time since diagnosis (F=2.86, p<0.05). There
was higher demoralization in hospitalization status, continued
treatment, lung cancer patients, and diagnosis during one to
2 years.
Predictors and mediating factors influencing suicidal ideation
In summary, the results of the Tobit regression analysis
(Table 2) show that marital status, psychological dis-
tress, and demoralization were effective predictors of
suicidal ideation. Model 4 shows that, compared with
psychological distress and depression, demoralization
was a more significant predictor of suicidal ideation
(t=2.84, p<0.01). Model 5, in which the various sub-
components of demoralization are compared, shows that
loss of meaning (t=2.54, p<0.05) was a more significant
predictor of suicidal ideation.
Results of the Sobel test (Table 3, Fig. 1) indicate that
the effects of psychological distress on suicidal ideation
were mediated by depression and demoralization, with
mediating effect sizes of 50 and 77 %, respectively. This
implies that patients with cancer who show signs of
depression or demoralization and apparent psychological
distress will experience an indirect increase in the mag-
nitude of the effects of depression or demoralization on
suicidal ideation by 50 and 77 %, respectively. On the
other hand, when both depression and demoralization
were set as mediating variables, the mediating effect size
was 75.4 %, of which depression accounted for 18 %,
demoralization 25 %, and depression×demoralization
31.8 %. Therefore, a depressed patient with cancer who
experiences demoralization syndrome will experience an
increased effect on suicidal ideation by 50–75.4 % above
the effect of depression alone.
The results of CART analysis (Fig. 2) indicate that level of
demoralization was the strongest predictor of suicidal idea-
tion. The 47 participants who were categorized as highly
demoralized had significantly higher levels of suicidal idea-
tion (mean=3.28, SD=4.79) than those with lower levels of
demoralization (mean=0.49, SD=1.25). Among highly
demoralized participants, 24 had high demoralization comor-
bid with depression; those patients had significantly higher
levels of suicidal ideation (mean=4.25, SD=6.11) than the
others (mean=2.26, SD=2.59).
Detecting psychological distress using DT, depression,
and demoralization
When using PHQ-9≥10 as the criterion for depression, the
AUC value for the DTscale was 0.79. The acceptable range of
AUC values is .5–1; higher AUC values indicate higher scale
accuracy, and the largest value on Youden’s index determines
the optimal cutoff point [48]. The results indicate that the DT
scale has acceptable discriminative ability as a screening tool
for depression, with an optimal cutoff of 5 points, sensitivity
of 76.9 %, and specificity of 73.9%. Using the demoralization
criterion of DS-MV ≥30 as a reference point, the AUC value
of the DT scale was 0.67, with an optimal cutoff of 5 points,
Table 2 TOBIT analysis of various variables with respect to suicidal
ideation
Variable β SE t p
Model 1
Never married 0.68 0.22 3.09** 0.002
Divorced 0.55 0.32 1.72 0.085
Widowed −0.18 0.52 −0.35 0.726
Married
Model 2
Never married 0.65 0.21 3.04** 0.002
Divorced 0.57 0.31 1.85 0.065
Widowed −0.02 0.51 −0.03 0.977
Distress 0.10 0.04 2.85** 0.004
Model 3
Never married 0.64 0.21 2.99** 0.003
Divorced 0.58 0.31 1.88 0.060
Widowed 0.02 0.51 0.04 0.966
Distress 0.06 0.04 1.63 0.104
Depression 0.04 0.02 1.91 0.056
Model 4
Never married 0.58 0.21 2.78** 0.005
Divorced 0.56 0.30 1.85 0.064
Widowed −0.13 0.50 −0.26 0.792
Distress 0.04 0.04 1.04 0.300
Depression 0.01 0.03 0.38 0.701
Demoralization 0.02 0.01 2.84** 0.005
Model 5
Never married 0.57 0.21 2.69** 0.007
Divorced 0.60 0.30 2.02* 0.043
Widowed −0.16 0.50 −0.31 0.753
Distress 0.04 0.04 0.93 0.352
Depression −0.01 0.05 −0.22 0.824
Loss of meaning 0.10 0.04 2.54* 0.011
Dysphoria 0.07 0.04 1.91 0.057
Disheartenment 0.01 0.04 0.33 0.740
Helplessness −0.08 0.05 −1.67 0.095
Sense of failure −0.03 0.04 −0.71 0.481
β Standardized coefficients, SE standard error, t tobit statistics
*p<0.05; **p<0.01
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sensitivity of 54.8 %, and specificity of 77.6 %. Using DS-
MV ≥42 as a reference point, the AUC value for the DT scale
was 0.77, with an optimal cutoff of 5 points, sensitivity of
80.6 %, and specificity of 72.2 %.
Thus, it can be seen that the DT (with a cutoff of 5 points) is
suitable for the preliminary screening of patients with depres-
sion or high levels of demoralization, but was not distinguish
in the severity of demoralization or depression.
Discussion
Comparisons of suicidal ideation, psychological distress,
depression, and demoralization with the results of other
studies
The results of this study reveal significant differences in
suicidal ideation with respect to marital status: unmarried
individuals had higher levels of suicidal ideation than married
patients did. This finding is similar to previous ones, whereby
married persons had lower suicide rates than unmarried ones
[50]. Marriage is an important source of social support (in-
cluding material and emotional support) that reduces suicidal
ideation [51].
With regard to psychological distress, 36 % of patients
in this study fulfilled the referral criteria for psychological
distress. This is similar to the results of previous studies,
whereby 35.1–37.8 % of patients with cancer experienced
apparent psychological distress [52, 53]. Moreover, the
results of this study showed that patients with lung cancer
had higher levels of psychological distress than those with
hematological malignancies, while patients aged 36–
50 years had higher levels of psychological distress than
those aged 51–65 or >65 years. These are similar to past
findings that associated different malignancies [24, 51, 52]
and younger age with higher levels of psychological dis-
tress [22, 54].
The results of this study showed that patients with lung
cancer, inpatients, and unemployed patients had higher levels
of depression than those who had hematological malignan-
cies, were inpatients, and were currently employed. These
results are similar to those of previous studies [55–58]. Not
only can employment provide economic support to patients
with cancer but it is also an important source of emotional
support [59, 60] and a way for patients to create social roles, as
it as an opportunity to connect with others and society, thus
improving self-identity [61]. Patients with cancer who stopped
working because of the disease or treatment might have lost
sources of self-identity and emotional support; this in turn
might have increased the risk associated with depression.
The patients’ mean demoralization score was 28.26±
13.32, with 42 % of patients assigned as highly
demoralized (DS-MV ≥30). This result is similar to
the findings of Kissane et al. [29] in Australia and
Mehnert et al. [33] in Germany, who found mean de-
moralization scores of 30.82±17.73 and 29.8±10.41,
respectively. According to various criteria, 39.1–47 %
of patients with cancer were highly demoralized. Pa-
tients with lung cancer, inpatients, and patients currently
receiving treatment had higher levels of demoralization
than patients with hematological malignancies, outpa-
tients, and patients who had discontinued treatment.
Table 3 Mediation analysis of
depression and demoralization on
psychological distress leading to
suicidal ideation
M1 18.1 %, M2 25.4 %, M1×M2
31.9 %




Depression 0.214 0.107 50 % +
Demoralization 0.214 0.076 77 % +
Depression (M1) and
demoralization (M2)
0.214 0.514 75.4 % +
Fig. 1 aDepression used as mediating variable; b demoralization used as
mediating variable. Note: *p<0.05, ***p<0.001
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These are similar to the results of previous studies,
which showed that different types of malignancies and
continuation vs. discontinuation of treatment resulted in
different levels of demoralization [35].
Fig. 2 CART analysis to predict
suicidal ideation
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Predictors of suicidal ideation
Compared with previous studies, which found that depression
was an important predictor of suicidal ideation [16, 18, 19], this
study’sTobit andCARTanalyses revealed thatdemoralization
had higher predictive power for suicidal ideation; further,
patients experiencing demoralization comorbid with depres-
sion had even higher levels of suicidal ideation. The results of
Sobel analysis were in line with the abovementioned results,
as demoralization can mediate between depression and sui-
cidal ideation. For patients with cancer and depressive ten-
dencies, the presence of demoralization increases the effect of
depression on suicidal ideation by 50–75.4 %. This result is
similar to the viewpoint proposed by Rickelman [62], which
suggests that the relationship between depression and demor-
alization is a continuous, depressogenic response. The only
deviating point made in this study is that Rickelman used
attributional arguments to propose that demoralization is a
precursor of depression; thus, when demoralization recurs
persistently or its severity increases, it will develop into de-
pression. In order to address these discrepancies in theory and
results, further studies can be conducted on highly
demoralized and highly depressed patients with cancer using
a longitudinal follow-up method to investigate the develop-
ment of the relationship between demoralization and
depression.
Furthermore, this study found that loss of meaning was an
important factor in the effect of demoralization on suicidal
ideation. This result is similar to that of previous studies that
showed that the loss of meaning subscale and the Schedule for
Attitudes toward Hastened Death (SAHD) were highly corre-
lated. This supports the hypothesis proposed by Kissane et al.
that demoralization independently predicts the desire for has-
tened death [29]. Current research has shown that improved
coping strategies that involve meaning-making in patients
with cancer can help them to adapt to their situation; these
can also be an important protective factor against depression
or demoralization [63–65] while reducing suicidal ideation
and improving spiritual well-being [66]. This section high-
lights the importance of meaningfulness in the reduction of
suicidal ideation in patients with cancer.
Optimal cutoff points in DTwith respect to PHQ-9
and DS-MV
The results reveal that the AUC value of the DT for detecting
depression was 0.79, which is an acceptable level of discrim-
inative ability. This result is similar to that of Hegel et al. [23],
who studied patients with preliminary diagnoses of breast
cancer; their administration of the DT gave an AUC value of
0.87. The only difference was that the previous study gener-
ated an optimal cutoff point of 7 points, which differs from the
cutoff of 5 points found in this study. Whereas that study
measured the length of time since preliminary diagnosis of
breast cancer and the decision to resect the tumor, this study
included patients who had had cancer for an average of
35 months, with patients who had had cancer for >2 years
accounting for a significant proportion of the group (41 %).
The results of Ozalp et al. [21] indicated that newly diagnosed
patients with cancer had higher levels of psychological dis-
tress than the ones diagnosed the previous year; thus, our
study estimated that time after diagnosis is an important factor
influencing the cutoff point of DT.
In addition, the results of this study show that the criteria of
DS-MV ≥30 or 42 points have acceptable levels of discrimi-
native ability with respect to demoralization; DS-MV ≥42 was
the most accurate reference point. This was in line with the
procedure ofMullane et al. [31], whereby mean±SDwas used
to categorize demoralization levels; this contrasts with the
method proposed by Kissane et al. [29], whereby the median
(30) was used as a cutoff for categorization; the present
method gives better discriminative ability.
The BSI was developed by Beck in West country; thus, it
may be necessary to account for cultural differences in atti-
tudes regarding life and death. Unlike the views of the original
authors, whereby accepting one’s fate or not actively avoiding
death when one’s life is threatened is seen as passive and
suicidal, the results of this study indicated that most patients
accepted the inevitability of death due to illness; this follows
from the fact that allowing nature to take its course is part of
the Taoist/Confucian cultural viewpoint. This reflects the in-
fluence of cultural differences on attitudes toward life and
death, which result in differing views on the definition of
passive suicidal intent. Therefore, the scale might have
misrepresented the severity of suicidal ideation in Taiwanese
patients with cancer; this problem cannot be completely ruled
out.
In summary, aside from the significant relationship
between depression and suicidal ideation that was re-
vealed in past studies, demoralization is also an impor-
tant risk factor that influences suicidal ideation in pa-
tients with cancer. The present results highlight that
highly demoralized patients have higher suicide risks
and require further attention for the purpose of suicide
prevention. The results indicate that the optimal cutoff
point for the DT is ≥5 points and that it has good
discriminative ability as a screening tool. Therefore,
the DT (with a cutoff of 5 points) can be used in
clinical settings for the preliminary screening of patients
with cancer comorbid with depression or high levels of
demoralization, tagging them as patients with high sui-
cide risk. The DS-MV and PHQ-9 can then be used to
determine the severity of demoralization or depression,
thus allowing for the provision of different treatments or
referral models in order to provide a complete screening
process for suicide prevention in patients with cancer.
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